Internal Medicine, Hematology & Oncology · Norwich, CT
NPI
1538144522
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
330 Washington St Suite 220, Eastern Ct Hematology & Oncology
Norwich, CT, 06360
Phone (860) 886-8362
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
122,952 services
Medicare patients, 2024
596
Average age 74
Drug cost, 2024
$2.6M
1,361 prescriptions
Company payments, 2025
$9,651
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dinesh Kapur was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 20,180 times for 14 patients. In total Dinesh Kapur billed 122,952 services in 167 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 20,180 | 14 | $2.33 | $47K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 9,690 | 13 | $0.29 | $2,793 |
| J0897 Injection, denosumab, 1 mg | Office | 8,221 | 35 | $20.45 | $168K |
| 85025 Blood Count | Office | 1,347 | 407 | $7.57 | $10K |
| 36415 Venipuncture Blood Collection | Office | 1,252 | 398 | $8.61 | $11K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,132 | 151 | $52.65 | $60K |
| 99214 Office E&M - Established | Office | 765 | 375 | $99.22 | $76K |
| 80053 Clinical Chemistry | Office | 699 | 258 | $10.31 | $7,205 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 640 | 20 | $0.09 | $57.9 |
| 83615 Clinical Chemistry | Office | 495 | 195 | $5.89 | $2,914 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 449 | 205 | $13.97 | $6,272 |
| 99215 Office E&M - Established | Office | 377 | 155 | $146.61 | $55K |
| 96372 Injection Administration | Office | 366 | 81 | $12.03 | $4,404 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 350 | 13 | $0.73 | $254 |
| 82784 Immunoassay | Office | 306 | 77 | $8.86 | $2,712 |
By year: 2022 $1.8M for 120,784 services; 2023 $2.4M for 127,979 services; 2024 $2.2M for 122,952 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,347 | 407 | $7.57 | $10K |
| 36415 Venipuncture Blood Collection | 1,252 | 398 | $8.61 | $11K |
| 80053 Clinical Chemistry | 699 | 258 | $10.31 | $7,205 |
| 83615 Clinical Chemistry | 495 | 195 | $5.89 | $2,914 |
| 82784 Immunoassay | 306 | 77 | $8.86 | $2,712 |
| 82728 Clinical Chemistry | 227 | 128 | $13.25 | $3,009 |
| 83540 Clinical Chemistry | 209 | 120 | $6.29 | $1,314 |
| 83550 Clinical Chemistry | 208 | 119 | $8.50 | $1,767 |
| 84443 Clinical Chemistry | 166 | 69 | $16.46 | $2,732 |
| 83735 Clinical Chemistry | 128 | 38 | $6.57 | $841 |
Medicare prescription drug claims, 2024
In 2024, the drug Dinesh Kapur prescribed most often to Medicare patients was Eliquis (Apixaban), with 160 prescriptions and refills. In total Dinesh Kapur wrote 1,361 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 160 | 309 | 42 | $180K |
| Xarelto Rivaroxaban | 138 | 312 | 38 | $170K |
| Levothyroxine Sodium Generic | 73 | 118 | 16 | $1,556 |
| Letrozole Generic | 71 | 185 | 24 | $2,240 |
| Ondansetron Odt Ondansetron | 52 | 52 | 36 | $580 |
| Hydroxyurea Generic | 47 | 88 | Under 11 | $407 |
| Omeprazole Generic | 45 | 88 | 19 | $396 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 39 | 53 | Under 11 | $119 |
| Prednisone Generic | 37 | 64 | 15 | $228 |
| Enoxaparin Sodium Generic | 35 | 44 | Under 11 | $7,671 |
| Dexamethasone Generic | 34 | 42 | 21 | $1,168 |
| Acyclovir Generic | 34 | 51 | Under 11 | $675 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 33 | 33 | 24 | $407 |
| Escitalopram Oxalate Generic | 31 | 57 | Under 11 | $350 |
| Gabapentin Generic | 29 | 55 | Under 11 | $602 |
Brand drugs: 444 claims; generic drugs: 917 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dinesh Kapur $9,651 ($9,651 in general payments such as food, travel and fees) from 41 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $5,621.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $5,621 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $286 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $285 |
| Pfizer Inc. PFE | 16 | $280 |
| Rigel Pharmaceuticals, Inc. RIGL | 8 | $272 |
| Janssen Biotech, Inc. JNJ | 10 | $227 |
| Celgene Corporation BMY | 11 | $218 |
| Merck Sharp & Dohme LLC MRK | 8 | $169 |
| Gilead Sciences, Inc. GILD | 8 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.